Discover 3,614 paid clinical trials in Orange County, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Orange County offers clinical trials for a variety of conditions, including high blood pressure, heart disease, and skin disorders such as eczema, alopecia, and psoriasis. The city’s medical institutions are actively recruiting both healthy volunteers, as well as those with specific health needs to participate in studies that could improve treatments and outcomes for these, and many other widespread health issues.
Filter
2
Filter results
Results: 3,614
A Study of BRIA-OTS Cellular Immunotherapy in Metastatic Recurrent Breast Cancer
for
Breast Cancer, Breast Tumor, Cancer of Breast,
Location: Santa Monica CA
Sponsor: BriaCell Therapeutics Corporation
Sex: All
Age: 18+
Code: NCT06471673
Phase 1, Phase 2, Recruiting
A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
for
Non-muscle-invasive Bladder Cancer
Location: Downey CA, Murrieta CA, Bakersfield CA, Mesa AZ,
Sponsor: SURGE Therapeutics
Sex: All
Age: 18+
Code: NCT05710848
Phase 1, Phase 2, Recruiting
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
for
Advanced Lung Cancer
Location: Beverly Hills CA, Los Angeles CA, Santa Monica CA,
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT06892548
Phase 1, Phase 2, Recruiting
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Location: Torrance CA, La Jolla CA, Ventura CA, Salinas CA,
Sponsor: Medtronic
Sex: All
Age: 0+
Code: NCT00271180
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations